These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 31914198)

  • 1. Molecular Characterization and Treatment of Pancreatic Neuroendocrine Tumors.
    De Jesus-Acosta AMC
    Oncology (Williston Park); 2019 Dec; 33(12):. PubMed ID: 31914198
    [No Abstract]   [Full Text] [Related]  

  • 2. ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors.
    Falconi M; Eriksson B; Kaltsas G; Bartsch DK; Capdevila J; Caplin M; Kos-Kudla B; Kwekkeboom D; Rindi G; Klöppel G; Reed N; Kianmanesh R; Jensen RT;
    Neuroendocrinology; 2016; 103(2):153-71. PubMed ID: 26742109
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuroendocrine gastroenteropancreatic tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up.
    Oberg K; Jelic S;
    Ann Oncol; 2008 May; 19 Suppl 2():ii104-5. PubMed ID: 18456741
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetics of pancreatic neuroendocrine tumors: implications for the clinic.
    Pea A; Hruban RH; Wood LD
    Expert Rev Gastroenterol Hepatol; 2015; 9(11):1407-19. PubMed ID: 26413978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuroendocrine tumors of the pancreas. Natural history and therapeutic options].
    Wiedenmann B
    Gastroenterol Clin Biol; 2003 Mar; 27(3 Suppl):S26-30. PubMed ID: 12704290
    [No Abstract]   [Full Text] [Related]  

  • 6. Endocan expression is correlated with poor progression-free survival in patients with pancreatic neuroendocrine tumors.
    Lin LY; Yeh YC; Chu CH; Won JGS; Shyr YM; Chao Y; Li CP; Wang SE; Chen MH
    Medicine (Baltimore); 2017 Oct; 96(41):e8262. PubMed ID: 29019897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Genetics and Genomic Data on Pancreatic Neuroendocrine Tumors: Implications for Diagnosis, Treatment, and Targeted Therapies.
    Schmitt AM; Marinoni I; Blank A; Perren A
    Endocr Pathol; 2016 Sep; 27(3):200-4. PubMed ID: 27456058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current status and therapeutic strategy for pancreatic neuroendocrine tumors in Japan].
    Ito T; Igarashi H; Jensen RT; Takayanagi R
    Fukuoka Igaku Zasshi; 2012 Jul; 103(7):131-7. PubMed ID: 22978065
    [No Abstract]   [Full Text] [Related]  

  • 9. Do morphologic characteristics play a role in nodal metastatic progression of well-differentiated pancreatic neuroendocrine tumors?
    Ugras N; Hasdemir S; Yerci Ö; Taşar P; Dündar HZ; Macunluoğlu AC
    Tumori; 2021 Feb; 107(1):80-85. PubMed ID: 32705937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occipital Headache as Initial Manifestation of a Pancreatic Neuroendocrine Tumor.
    Tsoukalas N; Triantafyllidis A; Tolia M; Galanopoulos M; Kostakis ID; Demiri S; Toumpanakis C; Koumakis G
    J Gastrointest Cancer; 2018 Dec; 49(4):501-503. PubMed ID: 28283989
    [No Abstract]   [Full Text] [Related]  

  • 11. Cases in the Management of GEP-NETs: Combination Regimens.
    Braiteh F
    Clin Adv Hematol Oncol; 2016 Apr; 14(4 Suppl 6):11-3. PubMed ID: 27167993
    [No Abstract]   [Full Text] [Related]  

  • 12. Pancreatic neuroendocrine tumors.
    Krampitz GW; Norton JA
    Curr Probl Surg; 2013 Nov; 50(11):509-45. PubMed ID: 24206780
    [No Abstract]   [Full Text] [Related]  

  • 13. Pancreatic neuroendocrine tumors: A review of serum biomarkers, staging, and management.
    Ma ZY; Gong YF; Zhuang HK; Zhou ZX; Huang SZ; Zou YP; Huang BW; Sun ZH; Zhang CZ; Tang YQ; Hou BH
    World J Gastroenterol; 2020 May; 26(19):2305-2322. PubMed ID: 32476795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification.
    Klöppel G; Couvelard A; Perren A; Komminoth P; McNicol AM; Nilsson O; Scarpa A; Scoazec JY; Wiedenmann B; Papotti M; Rindi G; Plöckinger U; ;
    Neuroendocrinology; 2009; 90(2):162-6. PubMed ID: 19060454
    [No Abstract]   [Full Text] [Related]  

  • 15. Neuroendocrine Tumors--Current and Future Clinical Advances.
    Chan JA; Kulke MH
    Hematol Oncol Clin North Am; 2016 Feb; 30(1):xiii-xiv. PubMed ID: 26614379
    [No Abstract]   [Full Text] [Related]  

  • 16. Biology and Systemic Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors.
    Raj N; Fazio N; Strosberg J
    Am Soc Clin Oncol Educ Book; 2018 May; 38():292-299. PubMed ID: 30231344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aggressive gastro-entero-pancreatic neoplasms.
    Coriat R
    Ann Endocrinol (Paris); 2019 Jun; 80(3):185-186. PubMed ID: 31064660
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of Pancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1: Some Clarity But Continued Controversy.
    Jensen RT; Norton JA
    Pancreas; 2017; 46(5):589-594. PubMed ID: 28426491
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnostic imaging of pancreatic neuroendocrine neoplasms (pNEN): tumor detection, staging, prognosis, and response to treatment.
    Baur AD; Pavel M; Prasad V; Denecke T
    Acta Radiol; 2016 Mar; 57(3):260-70. PubMed ID: 25855665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Öberg K; Knigge U; Kwekkeboom D; Perren A;
    Ann Oncol; 2012 Oct; 23 Suppl 7():vii124-30. PubMed ID: 22997445
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.